An association between atherosclerosis in the carotid ultrasonography and a novel risk factor of cardio-vascular diseases
An association between atherosclerosis in the carotid ultrasonography and a novel risk factor of cardio-vascular diseases
批准号:
16590525
负责人:
ADACHI Hisashi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2005
中文摘要
在日本普通人群中研究了血浆同型半胱氨酸(Hcy)、肝细胞生长因子(HGF)或不对称二甲基精氨酸(ADMA)浓度与高血压和颈动脉粥样硬化之间的关系。1999年,我们在日本田岛丸的一个农业社区对1,920名40岁或40岁以上的受试者进行了健康检查。我们测量了传统的危险因素,如体重指数(BMI)、血压(BP)、吸烟状况、总胆固醇、HDL-胆固醇和糖化血红蛋白A_<1c>。受试者接受B型颈动脉超声检查,以确定颈动脉内膜中层厚度(IMT)。在这些受试者中,分别在1,111例(452名男性和659名女性),1,474例(597名男性和877名女性)和712例(305名男性和407名女性)病例中测量了Hcy,HGF和ADMA水平。校正年龄、性别和肌酐水平后的多元线性回归分析显示,BMI(p<0.01)、收缩压和舒张压(p<0.001)、HDL-胆固醇(p<0.001)、糖化血红蛋白A_<1c>(p<0.001)和Hcy水平(p<0.05)与IMT显著相关。HGF水平与高血压的严重程度有关,但与IMT无关。相反,ADMA水平升高是颈动脉IMT的一个强有力的独立决定因素。除了传统的危险因素如高血压和糖代谢受损外,Hcy是颈动脉粥样硬化的一个新的危险因素。并且,我们在一项为期6年的颈动脉超声前瞻性研究中提出,血浆ADMA是颈动脉IMT进展的最强预测因子。
英文摘要
The relationships between plasma concentrations of homocysteine (Hcy), hepatocyte growth factor (HGF) or asymmetric dimethylarginine (ADMA) and hypertension as well as carotid atherosclerosis were examined in a Japanese general population. In 1999, we conducted a health examination in 1,920 subjects, aged 40 years or older in a farming community, Tanushimaru, Japan. We measured conventional risk factors such as body mass index(BMI), blood pressure (BP), smoking status, total cholesterol, HDL-cholesterol, and glycosylated hemoglobin A_<1c>. Subjects underwent B-mode carotid ultrasonography to determine the carotid intimal-medial thickness (IMT). Of these subjects, Hcy, HGF, and ADMA levels were measured in 1,111 (452 men and 659 women), 1,474 (597 men and 877 women) and 712 (305 men and 407 women) cases, respectively. With multiple linear regression analysis after adjustments for age, sex, and creatinine levels, BMI (p<0.01), systolic and diastolic blood pressure (p<0.001), HDL-cholesterol(p<0.001, inversely), glycosylated hemoglobin A_<1c> (p<0.001), and Hcy levels (p<0.05) were significantly related to IMT. Although HGF was related to the severity of hypertension, the levels were not related to IMT. On the contrary, elevated levels of ADMA were a strong and independent determinant of IMT of the carotid artery. In addition to conventional risk factors such as hypertension and impaired glucose metabolism, Hcy is a novel risk factor for carotid atherosclerosis. And, we suggested that plasma ADMA was the strongest predictor for the progression of carotid IMT in a prospective study for 6 years with carotid ultrasonography.
期刊论文(27)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.2337/diacare.28.10.2514
发表时间:
2005-10-01
期刊:
DIABETES CARE
影响因子:
16.2
作者:
[Satoh, A, Adachi, H, Imaizumi, T]
通讯作者:
Imaizumi, T
Elevated Asymmetric Dimethylarginene(ADMA) is Related to Carotid Atherosclerosis in a Japanese General Population
日本普通人群中不对称二甲基精烯 (ADMA) 升高与颈动脉粥样硬化有关
DOI:
--
发表时间:
2005
期刊:
Circulation Journal 69 SuppleII
影响因子:
--
作者:
[Kumiko Furuki, Hisashi Adachi, Mika Enomoto]
通讯作者:
Mika Enomoto
Novel risk factors for cardiovascular diseas : an epidemiological study in Tanushimaru, Japan, Physical Fithness and Health Promotion in Active Aging. Edited by Shiraki K, Sagawa S, Mohamed K. : Chapter 20
心血管疾病的新危险因素:日本田主丸的一项流行病学研究,积极老龄化中的身体健康和健康促进。
DOI:
--
发表时间:
2001
期刊:
影响因子:
--
作者:
[Adeachi H, et al.]
通讯作者:
et al.
Strong association between serum hepatocyte growth factor(HGF) and metabolic syndrome.
血清肝细胞生长因子(HGF)与代谢综合征之间有很强的相关性。
DOI:
--
发表时间:
2005
期刊:
J Clin Endocrinol Metab 90
影响因子:
--
作者:
[Hiratsuka A, Adachi H., et. al.]
通讯作者:
et. al.
Plasma levels of asymmetric dimethylarginine (ADMA) are related to intima-media thickness of the carotid artery
不对称二甲基精氨酸 (ADMA) 的血浆水平与颈动脉内膜中层厚度有关
DOI:
--
发表时间:
2006
期刊:
Atherosclerosis (in press)
影响因子:
--
作者:
[Furuki K, Adachi H, et al.]
通讯作者:
et al.
共 8 条
Is resting heart rate a risk factor for the development of future metabolic syndrome?
-
批准号:20590663
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.58万
-
财政年份:2008
-
负责人:ADACHI Hisashi
-
依托单位:
Is cytokine from adipose tissue associated with metabolic syndrome?
-
批准号:18590621
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.57万
-
财政年份:2006
-
负责人:ADACHI Hisashi
-
依托单位:
Serum hepatocyte growth factor concentration is related to hypertension-An epidemiological study-
-
批准号:14570368
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.62万
-
财政年份:2002
-
负责人:ADACHI Hisashi
-
依托单位:
Association of plasma remnant-like particle cholesterol with insulin resistance in a Japanese general population
-
批准号:12670374
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$0.32万
-
财政年份:2000
-
负责人:ADACHI Hisashi
-
依托单位:
国内基金
海外基金
登录
查看更多内容
ADMA通过NOX2/ROS/TGF-β通路调控视网膜纤维血管增殖的作用和机制
-
批准号:JCZRYB202501091
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
DDAH1水解ADMA影响其化学修饰Nrf2在腰椎软骨终板退变中的作用机制
-
批准号:82302732
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:黄保
-
依托单位:
糖尿病血管钙化新机制:FoxO1/DDAH1/ADMA 通路介导的血管平滑肌细胞成骨样表型转化
-
批准号:2022JJ30777
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2022
-
负责人:李年生
-
依托单位:
DDAH1通过ADMA调控H型血管内皮细胞的线粒体自噬在骨质疏松中的机制研究
-
批准号:82102591
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.0万元
-
批准年份:2021
-
负责人:谢子昂
-
依托单位:
ADMA/DDAHⅡ/eNOS/NO介导的阿霉素内皮毒性与铁死亡及葛根素干预机制
-
批准号:82160685
-
项目类别:地区科学基金项目
-
资助金额:34万元
-
批准年份:2021
-
负责人:何欢
-
依托单位:
基于代谢酶与转运体Oct2-DDAH1-Mate1/Oatp4c1通路的尿毒素ADMA肾脏清除机制研究
-
批准号:82060677
-
项目类别:地区科学基金项目
-
资助金额:33.0万元
-
批准年份:2020
-
负责人:于洋
-
依托单位:
PUFA omega-3通过调控miR-21/DDAH1/ADMA通路改善肺血管内皮功能失调在BPD并发肺高压中的机制研究
-
批准号:82001588
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:钟颖
-
依托单位:
基于LncRNAmeg3/miR-21调控ADMA探讨藤茶二氢杨梅素的内皮功能损伤保护机制
-
批准号:2018JJ3731
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2018
-
负责人:谭胜蓝
-
依托单位:
基于miRNA-21网络调控ADMA水平探讨藤茶二氢杨梅素对内皮损伤的保护机制研究
-
批准号:81703818
-
项目类别:青年科学基金项目
-
资助金额:20.0万元
-
批准年份:2017
-
负责人:谭胜蓝
-
依托单位:
甲基化核蛋白p90aDMA在PD-L1抗体治疗乳腺癌中的作用和机制
-
批准号:81602700
-
项目类别:青年科学基金项目
-
资助金额:17.0万元
-
批准年份:2016
-
负责人:曹雪蕾
-
依托单位: